Osteopenia Withdrawn Phase 3 Trials for Ethinylestradiol (DB00977)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00117260Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral DensityTreatment